These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 183829)

  • 1. Ontogenetic changes in levels of phosphodiesterase for adenosine 3':5'-monophosphate and glucosine 3':5'-monophosphate in the lung, brain and heart from guinea pigs.
    Davis CW; Kuo JF
    Biochim Biophys Acta; 1976 Sep; 444(2):554-62. PubMed ID: 183829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression of cytidine 3':5'-cyclic monophosphate phosphodiesterase activity in developing tissues of guinea pigs.
    Helfman DM; Brackett NL; Kuo JF
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4422-5. PubMed ID: 212750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in relative levels of guanosine-3':5'-monophosphate-dependent and adenosine-3':5'-monophosphate-dependent protein kinases in lung, heart, and brain of developing guinea pigs.
    Kuo JF
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2256-9. PubMed ID: 166381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.
    Azhar S; Menon KM
    Eur J Biochem; 1977 Feb; 73(1):73-82. PubMed ID: 190011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic nucleotide hydrolysis in the thyroid gland. General properties and key role in the interrelations between concentrations of adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate.
    Erneux C; Van Sande J; Dumont JE; Boeynaems JM
    Eur J Biochem; 1977 Jan; 72(1):137-47. PubMed ID: 12974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of the activator-dependent cyclic nucleotide phosphodiesterase from bovine heart.
    Donnelly TE
    Biochim Biophys Acta; 1977 Jan; 480(1):194-203. PubMed ID: 188479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic nucleotide phosphodiesterase activities of the fetal and mature human cerebral cortex.
    Kang ES
    Pediatr Res; 1977 May; 11(5):655-63. PubMed ID: 193085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic and regulatory properties of two forms of bovine heart cyclic nucleotide phosphodiesterase.
    Ho C; Teo TS; Desai R; Wang JH
    Biochim Biophys Acta; 1976 Apr; 429(2):461-73. PubMed ID: 177071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-dependent cyclic nucleotide phosphodiesterase from brain: comparison of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate as substrates.
    Brostrom CO; Wolff DJ
    Arch Biochem Biophys; 1976 Jan; 172(1):301-11. PubMed ID: 175742
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of SCH 15280, a new bronchodilator, on cyclic 3',5'-nucleotide phosphodiesterase activity and cyclic 3',5'-adenosine monophosphate levels in guinea pig lung.
    Kreutner W; Sherwood JE
    Biochem Pharmacol; 1977 May; 26(10):951-4. PubMed ID: 193512
    [No Abstract]   [Full Text] [Related]  

  • 11. The adnosine 3',5'-monophosphate and guanosine 3',5'-monophosphate phosphodiesterases from human lung tissue.
    Green D; Guy G; Moore JB
    Life Sci; 1977 Apr; 20(7):1157-62. PubMed ID: 191714
    [No Abstract]   [Full Text] [Related]  

  • 12. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases.
    Donnelly TE
    Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclic 3':5'-nucleotide phosphodiesterase determined in various human tissues by DEAE-cellulose chromatography.
    Hidaka H; Yamaki T; Ochiai Y; Asano T; Yamabe H
    Biochim Biophys Acta; 1977 Oct; 484(2):398-407. PubMed ID: 199262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
    Hidaka H; Asano T
    Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate phosphodiesterases.
    Bergstrand H; Kristoffersson J; Lundquist B; Schurmann A
    Mol Pharmacol; 1977 Jan; 13(1):38-43. PubMed ID: 189182
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytidine 3',5'-monophosphate phosphodiesterase: decreased activity in the regenerating and developing liver.
    Shoji M; Brackett NL; Kuo JF
    Science; 1978 Sep; 201(4358):826-8. PubMed ID: 210503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotide phosphodiesterase in silkworm. Developmental change of cyclic AMP and cyclic GMP phosphodiesterases.
    Morishima I
    Biochim Biophys Acta; 1975 Sep; 403(1):106-12. PubMed ID: 240422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple cyclic nucleotide phosphodiesterase activities from rat tissues and occurrence of a calcium-plus-magnesium-ion-dependent phosphodiesterase and its protein activator.
    Kakiuchi S; Yamazaki R; Teshima Y; Uenishi K; Miyamoto E
    Biochem J; 1975 Jan; 146(1):109-20. PubMed ID: 167710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the inhibition of phosphodiesterase activity and allergic histamine release by disodium cromoglycate and compound I.C.I. 74917.
    Barrett-Bee K; Henderson W
    Biochem Soc Trans; 1976; 4(4):699-701. PubMed ID: 63402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.